Author

Yongsheng Pang

Institution: University of California, Irvine

Observed institution: University of California, Irvine

OpenAlex ID: A5013862425

Adverse events of sorafenib in hepatocellular carcinoma treatment.

2022 · Yongsheng Pang, Aydin Eresen, et al. · PubMed Central · 26

Early assessment of irreversible electroporation ablation outcomes by analyzing MRI texture: preclinical study in an animal model of liver tumor.

2022 · Aydin Eresen, Kang Zhou, et al. · PubMed Central · 5

Works count: 2

Citation count: 31

H-index: 2

I10-index: 1